Genetics & Genomics (Hematology) : NIDDK

Genetics & Genomics (Hematology)

Specific areas include:

Development and application of genomic and genetic tools relevant to the understanding and treatment of hematologic diseases.
Genomic analysis of hematopoiesis and hematopoietic tissues across species.
Development of genetically modified model organisms relevant to understanding hematopoietic and erythropoietic diseases.
Development and application of genomic mapping techniques to identify disease modifying genes that affect the expression of inherited and acquired hematologic diseases.
Design and development of gene targeting techniques to correct gene mutations or selectively modify gene expression for the treatment of hematologic diseases.

For more information, contact Dr. Daniel Wright, or Dr. Terry Rogers Bishop, Program Directors, Hematology Basic Research.

Dr. Beena Akolkar, Immunopathogenesis and Genetics of Type 1 Diabetes Program Director
Dr. Terry Bishop, Hematology Research Programs Director
Dr. Olivier Blondel, Director, Endocrine Systems Biology Program
Dr. Arthur Castle, Director, Metabolomics and Informatics Programs
Dr. Edward Doo, Director of the Liver Diseases Program
Dr. Robert Karp, Director of the Genetics and Genomics Programs in Digestive Diseases and Nutrition
Dr. Catherine McKeon, Senior Advisor for Genetic Research in Diabetes, Endocrinology and Metabolic Diseases
Dr. Aaron Pawlyk, Director, Pharmacogenomics and Drug Discovery Program
Dr. Rebekah Rasooly, Deputy Director of the Division of Kidney, Urologic, and Hematologic Diseases
Dr. Daniel Wright, Hematology Research Programs Director